Christoph E. Dumelin is an Asscociate Director and group leader at the Novartis Institutes of Biomedical Research in Basel, Switzerland. His team is developing encoded library technologies and applying them to drug discovery research with a special emphasis on novel drug modalities including radio ligand therapeutics. Before working at Novartis, he worked on DNA-encoded libraries at X-Chem Pharmaceuticals, Waltham, Massachusetts, USA, and on whole-blood pool contrast agents at Philochem, Zurich, Switzerland. He obtained his M.Sc. in biochemistry from the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland, and his Ph.D. in pharmaceutical sciences at the ETH Zurich with Dario Neri. He completed his postdoctoral training in chemical biology with David Liu at Harvard University, Cambridge, USA.